Fatty liver disease (MASLD/MASH) trials in Mexico

In Mexico 11 Also abroad 367

11 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
Where
Acapulco de Juárez, Cuauhtémoc, Mexico City
Age
18 years to 80 years
People
1,650 worldwide
Run by
Akero Therapeutics, Inc
See details and how to joinNCT06215716
No phaseEnrolling by invitation
Effect of Ancestry Supplementation in Subjects With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Where
Guadalajara
Age
18 years to 60 years
People
60
Run by
University of Guadalajara
See details and how to joinNCT07592013
Phase 3Taking people
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
Where
Acapulco de Juárez, Col. Xoco, Cuernavaca, Mérida, Mexico City, Veracruz, Xalapa
Age
18 years and over
People
1,800 worldwide
Run by
Boehringer Ingelheim
See details and how to joinNCT06632444 · EU 2024-513739-25-00
Phase 3Taking people
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
Where
Acapulco de Juárez, Col. Xoco, Cuernavaca, Mérida, Mexico City, Veracruz, Xalapa
Age
18 years and over
People
1,590 worldwide
Run by
Boehringer Ingelheim
See details and how to joinNCT06632457 · EU 2024-513741-36-00
Phase 3Taking people
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Where
Chihuahua City, Cuautitlán Izcalli, Jalisco, Mexico City, Morelos, Nuevo León, Yucatán
Age
18 years to 80 years
People
1,350 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT06318169 · EU 2023-509912-27-00
Phase 3Taking people
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Where
Chihuahua City, Cuautitlán Izcalli, Cuernavaca, Jalisco, Mérida, Mexico City, Monterrey
Age
18 years to 75 years
People
1,800 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT06419374 · EU 2023-510395-31-00
Phase 3Taking people
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
Where
Acapulco de Juárez, Benito Juárez, Cuauhtémoc, Guadalajara, Mérida, Mexico City
Age
18 years to 80 years
People
2,150 worldwide
Run by
Akero Therapeutics, Inc
See details and how to joinNCT06528314
Phase 3Taking people
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Where
Chihuahua City, Cuauhtémoc, Cuernavaca, Guadalajara, Mérida, Metepec, Mexico City, Monterrey, Morelia, San Pedro Garza García, Veracruz, Zapopan
Age
18 years and over
People
4,500 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07165028 · EU 2025-522674-36-00
Phase 4Taking people
Fibrosis Lessens After Metabolic Surgery
Where
Mexico City
Age
18 years to 75 years
People
120 worldwide
Run by
The Cleveland Clinic
See details and how to joinNCT06374875
No phaseNot yet taking people in Mexico
Effect of a Low AGE Diet on Liver Function in Adults With Fatty Liver.
Where
Celaya
Age
18 years to 55 years
People
48
Run by
Universidad de Guanajuato
See details and how to joinNCT07723196
No phaseNot yet taking people in Mexico
CARTIZ Registry: Cartilage, Arthropathy and Imaging Under Tirzepatide in Zone-stratified Cohorts - A Four-Institute Mexican Observational Registry
Where
Mexico City
Age
18 years and over
People
30
Run by
JULIO GRANADOS MONTIEL
See details and how to joinNCT07567378